STAT3 and cancer: Interestingly, cancer cells were more susceptible to concurrent modulation of any two of the EGFR, Src, and STAT3 proteins but not to the inhibition of the single proteins alone, thus suggesting the need for multiple-targeted therapy approaches for this deadly neoplasia.